« FDA Approvals - 3 Indian firms get FDA nod for sleep disorder drug | Main | FDA Approvals - Response Submitted to FDA Approvable Letter for Hypertension Compound Nebivolol »

Events (PharmiWeb) Who should attend? This intensive course has been


Events (PharmiWeb)
Who should attend? This intensive course has been designed to benefit those in the Pharmaceutical industry with responsibilities related to the Quality System being used by the FDA in its Drug cGMP Inspections.

MedaSorb Technologies Corporation Begins Trading on Frankfurt Stock Exchange (RedNova)
MedaSorb Technologies Corporation (OTCBB: MSBT)
 

©2006 FDA-News.com. All rights reserved.